NCT04353518 - Clinical Trial to Evaluate Mycobacterium w in Preventing COVID-19 in Subjects at Risk of Getting Infected With COVID-19 | Biotech Hunter

Enrollment

4,000

Participants

Timeline

Start Date

June 30, 2020

Primary Completion Date

March 30, 2021

Study Completion Date

May 30, 2021

Conditions

COVID-19

Interventions

DRUG

Suspension of heat killed (autoclaved) Mycobacterium w

Subjects randomized to Test arm will receive intraderma Mw in divided doses at least 2 cm away from first injection site in the deltoid region.

OTHER

Placebo

Subjects randomized to placebo arm will receive intraderma Placebo in divided doses at least 2 cm away from first injection site in the deltoid region.

Trial Locations (3)

110029

RECRUITING

All lndia Institute of Medical Science, Delhi, Delhi

462024

RECRUITING

All India Institute of Medical Sciences, Bhopal, Bhopal

160012.

RECRUITING

Post Graduate Institute of Medical Education and Research, Chandigarh